BioStock: Curasight can look back on an eventful year

When reporting 2022, the Danish cancer company Curasight describes the year as eventful. The year’s primary focus was the strategic work, which the company now hope will lead to collaborations. BioStock contacted CEO Ulrich Krasilnikoff who tells us about the past year and the plans for 2023.

Read the full article about Curasight at biostock.se:

https://www.biostock.se/en/2023/03/curasight-can-look-back-on-an-eventful-year/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/